腺瘤多体内腺癌的生存差异:国家癌症数据库分析
Catherine S Taghizadeh1, Beau Hsia1, Yanick Tade2
1Department of Medicine, Creighton University School of Medicine, Phoenix, USA.
Cureus
|June 25, 2025
概括
这项研究表明,年龄较大,男性性别,黑人种族和晚期癌症阶段与腺瘤多体内的腺癌存活率较差有关. 诸如医疗保险/医疗补助保险和较高的并发症评分等因素也会对患者的治疗结果产生负面影响.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 流行病学 流行病学
背景情况:
- 腺瘤多体内的腺癌是一种罕见的恶性瘤,治疗信息有限.
- 这种情况发展缓慢,只有很少一部分的息肉变得恶性.
研究的目的:
- 确定影响腺癌瘤患者在腺瘤多体内生存的人口和预后因素.
- 在这个患者队列中分析整体存活率和死亡率.
主要方法:
- 在2004-2020年期间使用国家癌症数据库 (NCDB) 诊断的58,643名患者进行了回顾性队列研究.
- 使用卡普兰-梅尔曲线,多变量考克斯比例危险回归和LOESS进行统计分析.
- 组织学代码8210用于患者识别.
主要成果:
- 年龄较大,男性性别,黑人种族和晚期癌症阶段与明显较差的生存率有关.
- 患有医疗保险/医疗补助保险和较高的查尔森-迪约并发症得分的患者死亡风险增加.
- 第四阶段癌症与第一阶段相比,死亡风险增加了10倍.
结论:
- 影响生存的关键因素包括年龄,性别,种族,保险状况,并发症评分和癌症阶段.
- 更低的教育水平和收入水平也与生存结果的下降有关.
- 这项研究突出了改善这种罕见癌症的预后评估和患者护理的关键变量.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
201
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
920
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Comparing the Survival Analysis of Two or More Groups
302
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
302
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
